Stock screenerAll disclosures →
EDGAR →
QDEL
Conviction 26HealthcareScan · Fri, Jun 26, 2026QDEL$13.78+1.89%
ResistanceSupportVol 14Vol MA14 1.66M
Mar 27Apr 15May 4May 20Jun 9Jun 26
Price13.78
Change+1.89%
Gap+0.96%
Rel volume1.38×
Avg volume1.65M
Avg $ vol22.58M
SMA 2013.61
SMA 5012.49
SMA 20022.21
Price vs 50+10.33%
Price vs 200-37.99%
MA stackmixed
50/200 cross—
Supertrendup · 11.60
RSI (14)54
MACD hist-0.09
MACD crossbear · 5d
Stoch %K / %D58 / 38
ADX (14)19
+DI / −DI27 / 20
RSI divergence—
MACD divergence—
ATR %+7.39%
ADR %7.34%
52w high35.38
52w low9.96
From 52w high-61.07%
Above 52w low+38.30%
New 52w highNo
SqueezeOff
Bollinger width23.74%
%B0.55
Donchian pos49.36%
Donchian high15.76
Donchian low11.84
AVWAP (52w high)16.06
vs AVWAP high-14.22%
AVWAP (52w low)12.62
vs AVWAP low+9.16%
OBV trendUp
Chaikin MF (20)0.04
Today vs 20d1.38×
Avg vol (14d)1.66M
Avg vol (20d)1.65M
Avg $ vol (20d)22.58M
Market cap—
RS 3m (vs SPY)-27.35%
RS 6m (vs SPY)-61.87%
RS line new highNo
Trend template2/8
Technical rank36.4
1 week+0.77%
1 month+11.72%
3 months-11.70%
6 months-51.82%
1 year-51.00%
YTD-52.14%
P/E-0.82
P/B0.50
P/S0.34
P/FCF-11.12
EPS-16.69
Div yield—
ROE-61.13%
ROA-20.11%
Debt/Eq1.58
Current1.43
EV/EBITDA-7.77
Gross margin—
Net margin-41.45%
Rev growth-1.89%
EPS growth44.84%
Price target12.13
Target upside-10.35%
Analyst ratingHold
Institutional132.80%
Ent. value3.71B
Revenue619.8M
Net income-91.8M
Gross profit—
Free cash flow-83M
IndustryIN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
ExchangeNasdaq
Shares out68.19M
Employees6.5K
ListedTue, Aug 4, 1981
Free float—
Float %—
Short interest—
Days to cover—
Short volume—
Squeeze score—
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeD
Conviction26 / 100
Pattern quality—
Tech rank36.4 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance15.38
Support10.07
Days since event—
Candle confirm—
News sentiment—
Financials as of Sun, Mar 29, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in QDEL
No recent disclosed trades by Congress in QDEL. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in QDEL · 5 buys · 5 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
BUECHLER KENNETH F Director · Common Stock · 2026-06-06 | Grant | 497 | $0 | 2026-06-06 | 2026-06-09 |
BUECHLER KENNETH F Director · Restricted Stock Units (Premium) · 2026-06-06 | Exercise | 497 | $0 | 2026-06-06 | 2026-06-09 |
WIDDER KENNETH J Director · Common Stock · 2026-06-06 | Grant | 910 | $0 | 2026-06-06 | 2026-06-09 |
POLAN MARY LAKE PH D Director · Restricted Stock Units (Premium) · 2026-06-06 | Exercise | 224 | $0 | 2026-06-06 | 2026-06-09 |
Michael Edward L. Director · Restricted Stock Units (Converted) · 2026-06-06 | Exercise | 963 | $0 | 2026-06-06 | 2026-06-09 |
Michael Edward L. Director · Common Stock · 2026-06-06 | Grant | 289 | $0 | 2026-06-06 | 2026-06-09 |
BUECHLER KENNETH F Director · Common Stock · 2026-06-06 | Grant | 1.66K | $0 | 2026-06-06 | 2026-06-09 |
BUECHLER KENNETH F Director · Restricted Stock Units (Converted) · 2026-06-06 | Exercise | 1.66K | $0 | 2026-06-06 | 2026-06-09 |
POLAN MARY LAKE PH D Director · Restricted Stock Units (Converted) · 2026-06-06 | Exercise | 749 | $0 | 2026-06-06 | 2026-06-09 |
POLAN MARY LAKE PH D Director · Common Stock · 2026-06-06 | Grant | 224 | $0 | 2026-06-06 | 2026-06-09 |
SEC filings
EDGAR filings in QDEL · 2 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.